CGEM
Companies
NASDAQ
Cullinan Therapeutics Inc.
Health Care
$8.16
-$4.02 (-33.00%)
Price Chart
Overview
About CGEM
cullinan oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. sourced from the cullinan dry lab as well as external collaborators, cullinan’s assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.
Market Cap
$1.3B
Volume
3.4M
Avg. Volume
3.6M
P/E Ratio
-2.1830769
Dividend Yield
0.00%
Employees
79.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.79
Moderate Correlation
Volatility
High (0.60)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CGEM shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.3B
Volume3.4M
P/E Ratio-2.18
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025